2025 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · paywalled
Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat
Mucci et al.
The finding, in our words
The study validated a method for measuring cystic fibrosis drugs in dried blood spots, showing statistical equivalence to plasma concentrations, which supports their use as a less invasive alternative for therapeutic drug monitoring. It also found higher drug levels in nasal swabs, indicating localised accumulation at the disease site, which could inform more personalised treatment.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.